New Results
Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19
View ORCID ProfileJing Li, View ORCID ProfileMaxim Zaslavsky, Yapeng Su, Michael J. Sikora, View ORCID ProfileVincent van Unen, View ORCID ProfileAsbjørn Christophersen, Shin-Heng Chiou, Liang Chen, Jiefu Li, View ORCID ProfileXuhuai Ji, Julie Wilhelmy, View ORCID ProfileAlana M. McSween, Brad A. Palanski, View ORCID ProfileVenkata Vamsee Aditya Mallajosyula, View ORCID ProfileGopal Krishna R. Dhondalay, Kartik Bhamidipati, Joy Pai, Lucas B. Kipp, Jeffrey E. Dunn, View ORCID ProfileStephen L. Hauser, Jorge R. Oksenberg, View ORCID ProfileAnsuman T. Satpathy, View ORCID ProfileWilliam H. Robinson, View ORCID ProfileLars M. Steinmetz, View ORCID ProfileChaitan Khosla, View ORCID ProfilePaul J. Utz, View ORCID ProfileLudvig M. Sollid, View ORCID ProfileJames R. Heath, Nielsen Q. Fernandez-Becker, View ORCID ProfileKari C. Nadeau, View ORCID ProfileNaresha Saligrama, View ORCID ProfileMark M. Davis
doi: https://doi.org/10.1101/2021.12.23.473930
Jing Li
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Maxim Zaslavsky
2Program in Computer Science, Stanford University, Stanford, CA, USA
Yapeng Su
3Institute for Systems Biology, Seattle, WA, USA
Michael J. Sikora
4Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
Vincent van Unen
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Asbjørn Christophersen
5KG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway
6Institute of Clinical Medicine, University of Oslo, Oslo, Norway
7Department of Immunology, University of Oslo, Oslo, Norway
Shin-Heng Chiou
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Liang Chen
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Jiefu Li
8The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA
Xuhuai Ji
9Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, CA, USA
Julie Wilhelmy
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Alana M. McSween
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Brad A. Palanski
10Department of Chemistry, Stanford University, Stanford, CA, USA
Venkata Vamsee Aditya Mallajosyula
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Gopal Krishna R. Dhondalay
11Sean N Parker Center for Allergy and Asthma Research, Department of Medicine, Stanford University, Stanford, CA, USA
Kartik Bhamidipati
12Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA
Joy Pai
12Program in Immunology, Stanford University School of Medicine, Stanford, CA, USA
Lucas B. Kipp
13Division of Neuroimmunology, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
Jeffrey E. Dunn
13Division of Neuroimmunology, Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA
Stephen L. Hauser
14Department of Neurology and UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA
Jorge R. Oksenberg
14Department of Neurology and UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA, USA
Ansuman T. Satpathy
15Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA
William H. Robinson
16VA Palo Alto Health Care System, Palo Alto, CA, USA
17Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA
Lars M. Steinmetz
4Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA
18Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA
19European Molecular Biology Laboratory (EMBL), Genome Biology Unit, Heidelberg, Germany
Chaitan Khosla
10Department of Chemistry, Stanford University, Stanford, CA, USA
20Department of Chemical Engineering, Stanford University, Stanford, CA, USA
21Stanford ChEM-H, Stanford University, Stanford, CA, USA
Paul J. Utz
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
17Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA
Ludvig M. Sollid
5KG Jebsen Coeliac Disease Research Centre, University of Oslo, Oslo, Norway
7Department of Immunology, University of Oslo, Oslo, Norway
22Department of Immunology, Oslo University Hospital, Oslo, Norway
James R. Heath
3Institute for Systems Biology, Seattle, WA, USA
23Department of Bioengineering, University of Washington, Seattle, WA, USA
Nielsen Q. Fernandez-Becker
24Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford, CA, USA
Kari C. Nadeau
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
11Sean N Parker Center for Allergy and Asthma Research, Department of Medicine, Stanford University, Stanford, CA, USA
Naresha Saligrama
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
Mark M. Davis
1Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA
8The Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, USA
25Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
Posted December 25, 2021.
Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19
Jing Li, Maxim Zaslavsky, Yapeng Su, Michael J. Sikora, Vincent van Unen, Asbjørn Christophersen, Shin-Heng Chiou, Liang Chen, Jiefu Li, Xuhuai Ji, Julie Wilhelmy, Alana M. McSween, Brad A. Palanski, Venkata Vamsee Aditya Mallajosyula, Gopal Krishna R. Dhondalay, Kartik Bhamidipati, Joy Pai, Lucas B. Kipp, Jeffrey E. Dunn, Stephen L. Hauser, Jorge R. Oksenberg, Ansuman T. Satpathy, William H. Robinson, Lars M. Steinmetz, Chaitan Khosla, Paul J. Utz, Ludvig M. Sollid, James R. Heath, Nielsen Q. Fernandez-Becker, Kari C. Nadeau, Naresha Saligrama, Mark M. Davis
bioRxiv 2021.12.23.473930; doi: https://doi.org/10.1101/2021.12.23.473930
Human KIR+CD8+ T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19
Jing Li, Maxim Zaslavsky, Yapeng Su, Michael J. Sikora, Vincent van Unen, Asbjørn Christophersen, Shin-Heng Chiou, Liang Chen, Jiefu Li, Xuhuai Ji, Julie Wilhelmy, Alana M. McSween, Brad A. Palanski, Venkata Vamsee Aditya Mallajosyula, Gopal Krishna R. Dhondalay, Kartik Bhamidipati, Joy Pai, Lucas B. Kipp, Jeffrey E. Dunn, Stephen L. Hauser, Jorge R. Oksenberg, Ansuman T. Satpathy, William H. Robinson, Lars M. Steinmetz, Chaitan Khosla, Paul J. Utz, Ludvig M. Sollid, James R. Heath, Nielsen Q. Fernandez-Becker, Kari C. Nadeau, Naresha Saligrama, Mark M. Davis
bioRxiv 2021.12.23.473930; doi: https://doi.org/10.1101/2021.12.23.473930
Subject Area
Subject Areas
- Biochemistry (11753)
- Bioengineering (8752)
- Bioinformatics (29201)
- Biophysics (14974)
- Cancer Biology (12100)
- Cell Biology (17413)
- Clinical Trials (138)
- Developmental Biology (9422)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18309)
- Genetics (12245)
- Genomics (16804)
- Immunology (11869)
- Microbiology (28098)
- Molecular Biology (11596)
- Neuroscience (60975)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2886)
- Systems Biology (7340)
- Zoology (1651)